Intervention Protocol

Intrathecal baclofen for treating spasticity in children with cerebral palsy

  1. Monika J Hasnat1,*,
  2. James E Rice2,
  3. Maureen E O'Donnell3

Editorial Group: Cochrane Movement Disorders Group

Published Online: 26 JAN 2004

DOI: 10.1002/14651858.CD004552


How to Cite

Hasnat MJ, Rice JE, O'Donnell ME. Intrathecal baclofen for treating spasticity in children with cerebral palsy (Protocol). Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD004552. DOI: 10.1002/14651858.CD004552.

Author Information

  1. 1

    Royal Children's Hospital, Queensland Paediatric Rehabilitation Service, Herston, Queensland, Australia

  2. 2

    The Royal Children's Hospital, Rehabilitation Service, Parkville, Australia

  3. 3

    Sunny Hill Health Centre For Children, Developmental Pediatrics, Vancouver, BC, Canada

*Monika J Hasnat, Queensland Paediatric Rehabilitation Service, Royal Children's Hospital, Herston Rd, Herston, Queensland, QLD 4006, Australia. monika.h@ausdoctors.net.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 26 JAN 2004

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

1.To determine the effectiveness of intrathecal baclofen in treating spasticity in children with cerebral palsy.

2.To identify the range of outcome measures used in the evaluation of ITB and to determine what other measures are needed.

3.To determine whether ITB reduces the need for subsequent orthopaedic surgery in children with spasticity.

4.To determine the safety of ITB therapy

5.To consider the economic implications of the therapy